Currently, the treatment of MG primarily revolves around cholinesterase inhibitors, glucocorticoids, immunosuppressants, intravenous immunoglobulin, plasmapheresis, and thymectomy (12). The gene discussed is BCHE; the disease is myasthenia gravis.